Publications by authors named "Vipulkumar Thummar"

Claim this Profile
E
Evaluation of the Safety and Efficacy of Trastuzumab Emtansine (T-DM1) Biosimilar in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: Findings From a Single-Center Retrospective Analysis in India.
Kaushal Patel, Vipulkumar Thummar, Priya Mehta

Cureus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report on Trastuzumab Emtansine (T-DM1) in a Patient With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer and Brain Metastases: Long-Term Treatment and Survival.
Vipul Doshi, Vipulkumar Thummar, Priya Mehta

Cureus· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-Paclitaxel-Based Systemic Approach to Achieving Complete Remission for Relapsed Stage III Endometrial Carcinoma: Insights From the Indian Subcontinent.
Prasanna Rammohan, Vipulkumar Thummar, Priya Mehta

Cureus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report on the Efficacy of Trastuzumab Emtansine in a Patient With Human Epidermal Growth Factor Receptor 2 Exon 20-Mutated Adenocarcinoma of the Lung.
Arun Warrier, Anu George, Vipulkumar Thummar, Priya Mehta

Cureus· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report.
Suman Kalyan Natarajan, Joice Crystal Danansezhian, Vipulkumar Thummar, Priya Mehta

Reports (MDPI)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study.
Viraj Lavingia, Vipulkumar Thummar, Priya Mehta

SAGE Open Med Case Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis